Plant-derived phenolic acids revive the power of tetracycline against drug-resistant bacteria
Peer-Reviewed Publication
Updates every hour. Last Updated: 3-Jun-2026 17:16 ET (3-Jun-2026 21:16 GMT/UTC)
Princeton engineers investigated the secret to grasshoppers' efficient gliding, inspiring a new approach for robotic flight.
A Korea University research team has discovered that pitavastatin, a widely used lipid-lowering drug, can directly inhibit the Mcl-1 protein—an essential survival factor for therapy-resistant triple-negative breast cancer (TNBC). By blocking Mcl-1–dependent mitochondrial protection, pitavastatin eliminates cancer stem-like cells, suppresses metastasis, and restores paclitaxel sensitivity in preclinical models. This repurposed drug may offer a safer, faster-to-deploy therapeutic strategy for patients with aggressive or chemotherapy-refractory TNBC.